Methylprednisolone in Patients With Cognitive Deficits in Post-COVID-19 Syndrome (PCS)

Condition:   Post-COVID-19 Syndrome Intervention:   Drug: Methylprednisolone Sponsor:   Charite University, Berlin, Germany Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials